These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32146176)

  • 21. Neuroprotective profile of the multitarget drug rasagiline in Parkinson's disease.
    Weinreb O; Amit T; Riederer P; Youdim MB; Mandel SA
    Int Rev Neurobiol; 2011; 100():127-49. PubMed ID: 21971006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel MAO-B inhibitors: potential therapeutic use of the selective MAO-B inhibitor PF9601N in Parkinson's disease.
    Unzeta M; Sanz E
    Int Rev Neurobiol; 2011; 100():217-36. PubMed ID: 21971010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of methylthiosemicarbazones as new reversible monoamine oxidase-B inhibitors for the treatment of Parkinson's disease.
    Mathew GE; Oh JM; Mohan K; Tengli A; Mathew B; Kim H
    J Biomol Struct Dyn; 2021 Aug; 39(13):4786-4794. PubMed ID: 32588753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel arylalkenylpropargylamines as neuroprotective, potent, and selective monoamine oxidase B inhibitors for the treatment of Parkinson's disease.
    Huleatt PB; Khoo ML; Chua YY; Tan TW; Liew RS; Balogh B; Deme R; Gölöncsér F; Magyar K; Sheela DP; Ho HK; Sperlágh B; Mátyus P; Chai CL
    J Med Chem; 2015 Feb; 58(3):1400-19. PubMed ID: 25627172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rational design, synthesis and biological evaluation of novel multitargeting anti-AD iron chelators with potent MAO-B inhibitory and antioxidant activity.
    Jiang X; Guo J; Lv Y; Yao C; Zhang C; Mi Z; Shi Y; Gu J; Zhou T; Bai R; Xie Y
    Bioorg Med Chem; 2020 Jun; 28(12):115550. PubMed ID: 32503694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isatin-tethered halogen-containing acylhydrazone derivatives as monoamine oxidase inhibitor with neuroprotective effect.
    Kumar S; Oh JM; Prabhakaran P; Awasti A; Kim H; Mathew B
    Sci Rep; 2024 Jan; 14(1):1264. PubMed ID: 38218887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzyloxynitrostyrene analogues - A novel class of selective and highly potent inhibitors of monoamine oxidase B.
    Van der Walt MM; Terre'Blanche G; Petzer JP; Petzer A
    Eur J Med Chem; 2017 Jan; 125():1193-1199. PubMed ID: 27855360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancing monoamine oxidase B inhibitory activity via chiral fluorination: Structure-activity relationship, biological evaluation, and molecular docking study.
    Wang Z; Yi C; Chen K; Wang T; Deng K; Jin C; Hao G
    Eur J Med Chem; 2022 Jan; 228():114025. PubMed ID: 34871839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 6-Benzyloxyphthalides as selective and reversible monoamine oxidase B inhibitors with antioxidant and anti-neuroinflammatory activities for Parkinson's disease treatment.
    Song Q; Yu G; Li W; Xu Y; Cong S; Liu X; Tan Z; Deng Y
    Bioorg Chem; 2022 Mar; 120():105623. PubMed ID: 35066317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. (Hetero-)(arylidene)arylhydrazides as Multitarget-Directed Monoamine Oxidase Inhibitors.
    Palakkathondi A; Oh JM; Dev S; Rangarajan TM; Kaipakasseri S; Kavully FS; Gambacorta N; Nicolotti O; Kim H; Mathew B
    ACS Comb Sci; 2020 Nov; 22(11):592-599. PubMed ID: 33047950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gamma-decanolactone: Preliminary evaluation as potential antiparkinsonian drug.
    Pflüger P; Pereira P; Loza MI; Brea J; Viña D; Kumar A; Fontenla JA
    Eur J Pharmacol; 2021 Sep; 906():174276. PubMed ID: 34174267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of enamides as new selective monoamine oxidase-B inhibitors.
    Kavully FS; Oh JM; Dev S; Kaipakasseri S; Palakkathondi A; Vengamthodi A; Abdul Azeez RF; Tondo AR; Nicolotti O; Kim H; Bijo Mathew
    J Pharm Pharmacol; 2020 Jul; 72(7):916-926. PubMed ID: 32246471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of novel 2-(4-(benzyloxy)-5-(hydroxyl) phenyl) benzothiazole derivatives as multifunctional MAO-B inhibitors for the treatment of Parkinson's disease.
    Cao Z; Wang X; Zhang T; Fu X; Zhang F; Zhu J
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2159957. PubMed ID: 36728713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoamine oxidase inhibition by selected dye compounds.
    de Beer F; Petzer JP; Petzer A
    Chem Biol Drug Des; 2020 Mar; 95(3):355-367. PubMed ID: 31834986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1455-71. PubMed ID: 15480846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The adenosine receptor affinities and monoamine oxidase B inhibitory properties of sulfanylphthalimide analogues.
    Van der Walt MM; Terre'Blanche G; Petzer A; Petzer JP
    Bioorg Chem; 2015 Apr; 59():117-23. PubMed ID: 25746740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of novel 2-hydroxyl-4-benzyloxybenzyl aniline derivatives as potential multifunctional agents for the treatment of Parkinson's disease.
    Cao Z; Fu X; Wang X; Zhang T; Zhong L; Xia Q; Zhu J
    Eur J Med Chem; 2023 Mar; 249():115142. PubMed ID: 36716641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and identification of a novel derivative of salidroside as a selective, competitive inhibitor of monoamine oxidase B with enhanced neuroprotective properties.
    Yang Z; Huang X; Lai W; Tang Y; Liu J; Wang Y; Chu K; Brown J; Hong G
    Eur J Med Chem; 2021 Jan; 209():112935. PubMed ID: 33097301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trimethoxy Crown Chalcones as Multifunctional Class of Monoamine Oxidase Enzyme Inhibitors.
    Maliyakkal N; Baysal I; Tengli A; Ucar G; Almoyad MAA; Parambi DGT; Gambacorta N; Nicolotti O; Beeran AA; Mathew B
    Comb Chem High Throughput Screen; 2022; 25(8):1314-1326. PubMed ID: 34082669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and evaluation of resveratrol-indazole hybrids as novel monoamine oxidases inhibitors with amyloid-β aggregation inhibition.
    Lan JS; Liu Y; Hou JW; Yang J; Zhang XY; Zhao Y; Xie SS; Ding Y; Zhang T
    Bioorg Chem; 2018 Feb; 76():130-139. PubMed ID: 29172101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.